Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
TORSEMIDE 10 MG + SPIRONOLACTONE 25 MG
Therapeutic Category
Cardiovascular, Cardiology
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*15
Price
₹209/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Torslide S 20/50 Tablet is a combination of Torsemide (20 mg), a loop diuretic, and Spironolactone (50 mg), a potassium-sparing diuretic. This formulation is primarily used to manage fluid retention (edema) and hypertension (high blood pressure) in conditions such as heart failure, liver disease, and kidney disorders.
Torsemide works by increasing urine output, which helps remove excess fluid from the body, reducing swelling and lowering blood pressure. On the other hand, Spironolactone prevents potassium loss caused by diuretics while also acting as an aldosterone antagonist, helping to regulate salt and water balance. Together, they provide an effective treatment for fluid overload while minimizing the risk of electrolyte imbalance.
Torslide S 20/50 is particularly beneficial for patients who need long-term diuretic therapy but are at risk of potassium depletion. It helps improve breathing, reduces swelling (edema) in the legs and abdomen, and enhances overall cardiovascular function.
May cause dizziness, dehydration, low blood pressure, electrolyte imbalance, muscle cramps, nausea, or increased urination.
Used for the treatment of hypertension and edema associated with heart failure, liver cirrhosis, and kidney disorders.
Should be used under medical supervision, with regular monitoring of electrolytes, kidney function, and blood pressure.
Store at 15°C to 30°C, in a cool and dry place, away from moisture and direct sunlight.
Composition : Torsemide 10mg Tablet
Composition : Torsemide 100mg Tablet
Composition : Torsemide 20 mg Tablet
Composition : Torsemide 40mg Tablet
Composition : Torsemide 5mg Tablet
Composition : Torsemide (10mg/ml) Injection
Composition : Torsemide 5 mg + Spironolactone 50 mg Tablet
Composition : Torsemide 20 mg + Spironolactone 50 mg Tablet
Composition : Torsemide 10mg + Spironolactone 50mg Tablets
Composition : Chlorthalidone 6.25mg Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Torasemide 10mg + Spironolactone 25mg Tablet is a popular formulation in the cardiology, nephrology, and internal medicine segment. With the rising incidence of cardiovascular disorders, fluid retention conditions, and kidney-related complications, this combination therapy enjoys strong prescription demand. It offers excellent business opportunities for pharma franchise partners, distributors, stockists, and wholesalers looking to expand their cardiac and renal care product portfolio.
Medical distributors and pharma franchise companies can benefit from the consistent demand for combination diuretic therapies prescribed under medical supervision. Torasemide 10mg is a loop diuretic that helps remove excess fluid from the body by increasing urine output Spironolactone 25mg is a potassium-sparing diuretic that helps manage fluid retention while helping maintain potassium balance Commonly prescribed for patients requiring combination diuretic therapy under medical guidance Frequently recommended by cardiologists, nephrologists, and physicians Combines complementary mechanisms of action to support effective fluid management strategies Widely utilized in hospitals, specialty clinics, and outpatient healthcare settings This combination strengthens a comprehensive cardiology, nephrology, and internal medicine portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Torasemide 10mg + Spironolactone 25mg Tablet. Franchise partners receive monopoly rights, promotional support, attractive packaging, competitive pricing, and reliable supply chain assistance to help establish and grow their pharmaceutical business successfully.
Wholesalers, distributors, and medical agencies can benefit from: Strong prescription demand in the cardiology and nephrology segments Regular repeat orders due to ongoing treatment requirements Wide acceptance among cardiologists, nephrologists, and general physicians Attractive profit margins and business growth opportunities Reliable product availability and efficient logistics support Enhanced cardiac and renal care product portfolio
Interested distributors, wholesalers, stockists, and pharma professionals can partner with Cafoli LifeCare Pvt Ltd to market Torasemide 10mg + Spironolactone 25mg Tablet across India. With exclusive monopoly-based franchise opportunities, comprehensive promotional support, quality-assured formulations, attractive business margins, competitive pricing, and dependable logistics assistance, Cafoli LifeCare Pvt Ltd helps partners build a successful and profitable pharmaceutical business.